Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
$ 7.72
-16.7 %
$ 418 M
Market Cap
-1.97
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
3.75%
EBIT
Estimate
49.57%
Net Income
Estimate
20.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Emergent BioSolutions Inc.
EBS has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart EBS
EBIT FORECAST
EBIT Forecast Chart EBS
NET INCOME FORECAST
Net Income Chart EBS